Roche Advances Infectious Disease Diagnostic Portfolio with US$1.8 B GenMark Acquisition

By Debadrita Paul & Michelle Liu

Pharma Deals Review: Vol 2021 Issue 4 (Table of Contents)

Published: 9 Apr-2021

DOI: 10.3833/pdr.v2021.i4.2605     ISSN: 1756-7874

Section: Mergers & Acquisitions



Roche has agreed to acquire GenMark, a multiplex molecular diagnostic (MD) solutions provider for infectious diseases, including bloodstream, respiratory and gastrointestinal infections...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details